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Abstract: This essay critically reviews the theory of biomedical ethics from a law-and-
economics perspective.  It suggests that the best direction for society is toward greater 
reliance on property rights and recognized spheres of autonomy, coupled with freedom of 
contract within specified limits; and that as a result, the role of the biomedical ethicist 
should be diminished over time rather than enhanced.  I consider applications to the duty 
of beneficence and commerce in body parts. 
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 Health law, a fast growing field of scholarship, appears to consist largely of two 
schools.  One focuses on health care antitrust, taking as its fundamental premise the 
notion that health care markets should be distinguished from and treated differently than 
other markets.  This premise underlying health care antitrust is based on a few recurring 
features of health care markets, such as informational asymmetry, that are taken as 
sufficient bases for treating them differently.1  The other school of health law is 
biomedical ethics, which has taken on increasing importance in view of the many 
tradeoffs that arise when health care intersects with the law.  Should, for example, a 
physician be required to disclose all of the risks of a procedure to the patient, even though 
disclosure might discourage the patient to his detriment?  Should a physician proceed 
with a kidney transplant after discovering that the patient has offered the donor a 
financial reward, or refuse to go forward on ethical grounds?  The view of biomedical 
ethicists is that they can develop a science of ethics that can be applied to answer these 
and many other tradeoff questions in health care law. 
 
This essay will focus on the biomedical ethics school of health law.  I am doubtful 
of the prospects for a science of ethics, based on the prevailing mode of analysis, that 
really helps resolve difficult health care policy tradeoffs in a manner that provides useful 
guidance for courts.  I will suggest that the best direction for society is toward greater 
reliance on property rights and recognized spheres of autonomy, coupled with freedom of 
contract within specified limits; and that as a result, the role of the biomedical ethicist 
should be diminished over time rather than enhanced.  Moreover, to the extent that the 
biomedical ethicist’s recommendations are needed as guidance for the law, they should 
be based on an empirically-grounded social welfare analysis rather than the invocation of 
ethical principles.2 
 
I. Questioning Basic Terms 
 
Biomedical ethics, in comparison to its sister legal ethics, is an advanced field of 
interdisciplinary scholarship.  Biomedical ethics textbooks date back to the 1803 
publication of Medical Ethics, written by Thomas Percival, a physician.  Today, the field 
is inhabited by PhDs in philosophy who spend time reading vignettes involving medical 
dilemmas, many of them from court cases, and linking the ethical problems raised in the 
vignettes with long standing problems in philosophy.  Unlike legal ethics, medical ethics 
has reached the stage that it is taken seriously by students of philosophy everywhere, and 
taught within philosophy departments as well as within medical schools.3  This is a level 
                                                 
1 Information asymmetry, and uncertainty generally, have been viewed as distinguishing features of health 
care markets since the publication of Kenneth Arrow’s essay on medical care, see Arrow, Kenneth J., 1963. 
Uncertainty and the welfare economics of medical care. American Economic Review, 53, 941–973. 
2 For a general argument favoring welfare analysis over ethical principles as justifications for legal rules, 
see Louis Kaplow and Steven Shavell, Fairness Versus Welfare (Harvard Univ. Press, 2002).  I recognize 
that this suggestion could lead to an expansion of the role of the biomedical ethicist.  However, it would be 
an expansion into a different role, based on informing participants of the social costs and benefits of their 
decisions and attempting to guide them toward socially optimal decisions. 
3 I do not wish this statement to be taken as a negative assessment of legal ethics – it is instead a 
comparatively positive assessment of medical ethics.  I realize that the field of legal ethics has drawn 
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of interdisciplinary interaction that legal ethics professors can only hope to see develop 
within their own fields someday.   
 
One of the top texts in the field is Beauchamp and Childress’s Principles of 
Biomedical Ethics.4  I will take this as a key source in presenting my critique of the field. 
It is a marvelous example of the integration of philosophical literature with the practical 
field of medicine.  I will refer to the Beauchamp and Childress textbook below as 
Biomedical Ethics and treat it as synonymous with the field. 
 
As someone outside of the field – and, in the interest of full disclosure, as a 
lawyer and economist – the first thing that struck me about Biomedical Ethics is the 
architecture of language.  Some of the language is familiar right away.  For example, 
biomedical ethicists distinguish normative ethical theory from positive or descriptive 
ethical theory.5  Normative ethical theory attempts to set out a prescription based on 
ethics of how things should be done.  Positive or descriptive ethical theory attempts to 
explain the ethical norms that seem to be consistent with the views expressed by medical 
professionals or the actions that they take.  These terms are similar to the familiar 
distinction in economics between normative and positive economic analysis; the former 
aiming to prescribe what should be done, the latter aiming to explain or justify economic 
conventions that exist. 
 
However, even here, working with terms that I find familiar, I am troubled by a 
difference in approach to the most basic terms.  When an economist presents a positive 
theory of some economic convention, he or she is usually attempting to explain some 
course of conduct that is observed and typically measurable.  For example, one well 
examined area of positive economic analysis is the prediction and testing of the 
employment effects of a minimum wage statute.6  The descriptive or positive ethical 
theories, however, attempt to describe the norms that are consistent with the views 
expressed by physicians on important policy issues. 
 
This is a distinction that deserves to be highlighted.  A theory that aims to explain 
the moral norms expressed by people runs into the problem that the people surveyed may 
not really believe in the moral norms that they are offering to account for their action.  
They may believe in other norms that would fail to merit respect as moral norms.  
Alternatively, they may be acting out of self interest without regard to morality, and find 
                                                                                                                                                 
increasing attention from philosophy professors.  But the number of philosophy professors studying legal 
ethics is far less than the number studying medical ethics. 
4 Tom L. Beauchamp and James F. Childress, Principles of Biomedical Ethics (5th ed., Oxford Univ. Press, 
2001).  For two other impressive textbooks, see Thomas A. Mappes and David DeGrazia, Biomedical 
Ethics (5th ed. McGraw-Hill, 2001) and Robert M. Veatch, A Theory of Medical Ethics (New York: Basic 
Books, 1981). 
5 Beauchamp and Childress, at 2 (distinguishing normative and nonnormative approaches to ethics). 
6 Theory predicts in the standard case, employment will fall as a result of the minimum wage, and most 
empirical studies confirm the prediction.  For a study challenging the standard theory and result, see David 
Card, Do Minimum Wages Reduce Employment?  A Case Study of California, 1987-89, 46 Industrial & 
Labor Relations Review 38 (1992). 
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that the use of moral norms to justify their conduct makes it easier for others to accept 
their actions. 
 
It is difficult to determine what really motivates someone to do something.  Moral 
justifications have the property that they stand in contrast and often in opposition to self 
interest.  For this reason, moral justifications will always appear attractive as concealing 
garments for conduct that is motivated by self interest.  This is the reason that 
professional associations have tended to use ethical codes as the primary instruments for 
establishing and policing collusive anticompetitive practices. 
 
To take an example, the American Medical Association Code of Ethics once 
prohibited physicians, on ethical grounds, from accepting salaried positions in connection 
with prepaid medical care.7  In other words, what is common today – physicians 
accepting salaries to work in Health Maintenance Organizations – was considered a 
serious ethical breach by the American Medical Association sixty-five years ago.  It is 
also true that today most physicians or medical ethicists would have a difficult time 
offering a persuasive ethical justification for the AMA’s early prohibition of salaried 
practice.  Indeed, there is no persuasive ethical justification.  The most plausible reason 
for the prohibition was to limit the entry of a low-cost competitor to the standard pay-for-
service system that used to prevail in the medical profession.  By any objective measure 
of social welfare, the introduction of salaried medical practice has been a benefit to 
society and has improved the public’s health. 
 
Given that only sixty-five years ago, professional associations were enjoining on 
ethical grounds conduct that is considered unworthy of comment or even socially 
beneficial today, one should consider the possibility that some conduct that is considered 
unethical today might be recognized as socially desirable in the future.  And if that 
occurs, we may want to look back and ask ourselves why we considered it unethical 
today.  Perhaps we will discover that the ethical justifications that were once offered were 
in fact hollow; that the real motivations had nothing to do with ethics.  However, the 
ethical justifications were useful precisely because they were hollow.  It is because a 
policy is based on self interest and is harmful to some set of interacting parties, such as 
consumers, that professionals have an interest in promoting ethical justifications as 
concealing garments.8 
 
This example should be sufficient to express my unease with some of the terms 
that appear to be of fundamental importance to Biomedical Ethics.  As a positive or 
descriptive theory, it invites questions about the motives behind our actions.  An 
uncooperative student of ethics might continue to raise questions about the balance of 
principle versus self interest as motivations for our actions.  A skeptic might doubt 
                                                 
7 See American Medical Association v. United States, 130 F.2d 233 (D.C. Cir. 1942), aff’d, 317 U.S. 519 
(1943). 
8 The point that ethical arguments are sometimes self serving has been noted before in the context of 
medical ethics.  See, e.g., Robin Hanson, Why Health is Not Special: Errors in Evolved Bioethics Intuitions 
in Bioethics 153, 170 (Ellen Frankel Paul, Fred D. Miller, Jr., and Jeffrey Paul, eds., 2002). 
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whether moral principles are ever the real motivations behind our actions, even when we 
have convinced ourselves that they are. 
 
Obviously, the skeptical view is vulnerable to the critique that it is disingenuous.  
If a man were to assert that all men habitually lie, we could not take his word if he also 
claims that he is a man telling the truth.  Similarly, one might argue that a generally 
disrespectful view toward ethical rationales is itself a contradictory position and 
unworthy of respect.  But the skeptical view suggested here is somewhat more limited.  It 
says nothing more than that moral and ethical justifications are sometimes hatched from a 
will to dissemble.  Non-moral and unethical justifications, especially those based on self 
interest, are less vulnerable to this critique.  To be more explicit, the skeptical view of 
ethics takes into account the strategic value of ethical arguments.  In a society consisting 
of some combination of genuine altruists and genuine egoists, the egoists would have a 
strong incentive to use ethical arguments in order to pool with the altruists.  By pooling 
with the altruists, the egoists would reduce the probability that a rational observer will 
discount their arguments.  Given this incentive, it is rational to approach ethical 
arguments with some degree of skepticism. 
 
To be sure, the skeptical view cannot be completely valid.  Hume, Smith, and 
others have explained that men are both genuinely interested in the welfare of others and 
in how they are regarded by others.9  Humans are by nature accountable.  They are 
capable of judging their own actions by the measure of an external observer.  The ability 
to empathize with others and to have an internal sense of the social desirability of 
following the Golden Rule no doubt provides a wellspring for moral and ethical 
principles.  A skeptic in the tradition of Bentham might doubt even this argument, but it 
seems plausible that humans would evolve to be social in precisely this sense. 
 
Our interest in being held in esteem by others, and thinking that this is deserved, 
should lead us to develop moral and ethical rules to guide our conduct.  However, it also 
leads us to develop ethical justifications as concealing garments for our motivations.  In 
primitive times, expropriation and murder were probably viewed as alternatives to 
contract.  This is thankfully not so today, but that does not mean that the baser impulses 
have entirely disappeared from our thought processes.  The language of contract has 
required somewhat softer, other-regarding, rationales for conduct. Evolution has probably 
rewarded those of us who developed the capacity to use such language. 
 
II. Take-it-or-leave-it Essentialism: Moral Excellence versus Self Interest 
 
In addition to the skeptical or even churlish questions that I cannot avoid asking 
about moral principles as genuine motivations for observed conduct, I am troubled by the 
peremptory essentialism that comes along with some of the basic terms in the language 
architecture of Biomedical Ethics.  Beauchamp and Childress describe the notion of 
moral excellence in a passage on Aristotle.   
 
                                                 
9 David Hume, An Inquiry Concerning the Principles of Morals (1751); Adam Smith, Theory of Moral 
Sentiments (1759).  
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An action can be right without being virtuous, [Aristotle] maintained, but 
an action can be virtuous only if performed from the right state of mind. 
Both right action and right motive are present in a virtuous action: “The 
agent must … be in the right state when he does [the actions].  First, he 
must know [that he is doing virtuous actions]; second, he must decide on 
them, and decide on them for themselves; and third, he must also do them 
from a firm and unchanging state,” including the right state of emotion 
and desire.10 
 
In this description of moral excellence, we learn that it does not matter that you have 
done something that appears by observable evidence to be morally appropriate if your 
state of mind is not right.  The external and immediate is given relatively little weight, 
and the internal motivation is given priority.  This is a view of ethics that appoints the 
ethicist as the sole judge of whether conduct is morally appropriate, regardless of its 
effects. 
 
Peremptory, as in take-it-or-leave-it, is one way of describing this exacting notion 
of moral excellence.  If, under the theory of ethics advanced by Beauchamp and 
Childress, the morality of conduct cannot be determined by observing available evidence 
– the conduct itself and its observable effects – then ordinary individuals are incapable of 
serving as judges of moral excellence.  Only a recognized judge of moral excellence, the 
biomedical ethicist or the “gatekeeping physician”,11 can serve as a judge.  Moreover, the 
ethicist’s assertion that someone or something possesses moral excellence is largely 
unassailable by an ordinary individual.  There are no accepted methods of testing an 
assertion of moral excellence against facts or objective measures. 
 
I have also described the notion of moral excellence advanced by Beauchamp and 
Childress as essentialist.  It is essentialist in the sense that it refers to some inherent 
quality in the nature of action and the actor, and not to the external conditions and effects 
of the action.  The theory aims to reward and promote this inherent quality, without 
regard to its observable effects.  Moral excellence, in this view, is like a gem that shines 
through the dust surrounding our actions.  A morally excellent person will have this gem-
like quality, even if his conduct is not obviously consistent with conventional moral 
objectives (e.g., helping the unfortunate, honesty, etc). 
 
Before considering the practical applications of this notion of moral excellence I 
should pause to state some objections that have been advanced before, perhaps most 
obviously by Popper, who coined the term essentialism, and certainly some strains of this 
critique appear in John Stuart Mill.  Take-it-or-leave-it ethical arguments are questionable 
because they demand of the ordinary individual that he sacrifice the authority to judge, on 
the basis of observable evidence, the morality of the conduct of others.  This is a system 
of ethics that appears to be inherently contradictory because it refuses to give full respect 
to the ordinary individual while at the same time expressing a great respect for autonomy 
as an abstract principle.  But if autonomy means anything, surely it must mean that every 
                                                 
10 Beauchamp and Childress, at 28. 
11 Id. at 49 (describing moral gatekeepers). 
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fair-minded individual is authorized, within the ethical system, to weigh the evidence on 
his own in order to determine whether the conduct of another person, or any specified 
course of conduct, is morally objectionable or unobjectionable.  A notion of moral 
excellence that denies the capacity of the ordinary individual to determine this quality by 
observing the conduct of others fails to respect the ordinary individual as a potential 
equal in status to the ethicist. 
 
In addition, there is the issue of proving or disproving the presence of moral 
excellence.  The ethicist might retreat and say, “oh sure, you can decide for yourself 
whether someone is behaving morally.  Nothing in this theory attempts to deny that to the 
individual.”  But the notion of moral excellence advanced by Beauchamp and Childress is 
something that cannot be tested against observable facts.  It is an inherent quality that is 
unobservable, and it tells us whether we have moved beyond being right to being 
virtuous.  It means nothing to tell me that I am free to attempt to determine the presence 
of this quality myself if I have no tools that would permit me to observe it or to prove or 
disprove its presence.  An ethical theory that respects the individual should do more than 
simply abjure take-it-or-leave-it propositions.  It should also tell us that these assertions 
can be tested against the facts of ordinary experience. 
 
Later, in an application, we get a glimpse of what the concept of moral excellence 
implies in a practical setting.  Beauchamp and Childress discuss the issue of organ 
donation.  Health care professionals, they assert, “sometimes function as moral 
gatekeepers to determine who may undertake variably risky acts of living donation of 
organ and tissues for transplantation.”12  It is appropriate, they argue, “for transplant 
physicians to consider potential donors’ motives, at least to the extent of investigating 
whether financial gain is the motivating factor.”13 
 
It is reassuring and a bit of a relief to see financial gain cited as an example of a 
failure of moral excellence.  Indeed, it is the only absolutely clear failure of virtue 
appearing in Beauchamp and Childress’s discussion of virtuous conduct.  The other 
examples they mention are various failures of competence, and the nurse’s mistake of 
being excessively obedient, zealous, or devoted to the attending physician.14 
 
                                                 
12 Beauchamp and Childress, at 49.  
13 Id. at 50.  The notion that financial gain should not play any role in the decision to donate an organ 
appears to be solidly entrenched among biomedical ethicists.  See, e.g., Leon Kass, Organs for Sale?  
Propriety, Property, and the Price of Progress, 107 The Public Interest 65 (1992).  Among transplant 
surgeons there appears to be a range of views – for example, at least one prominent transplant surgeon has 
rejected the position of the biomedical ethicists on this issue, see Arthur J. Matas, The Case for Living 
Kidney Sales: Rationale, Objections and Concerns, 4 Am. Journal of Transplantation 2007 (2004).  The 
biomedical ethicists’ arguments against financial gain to organ donors typically follow Kantian lines.  
However, as I noted in an earlier contribution to this journal, the modern ethicists are typically stricter and 
recognize fewer exceptions than the original argument against the selling of body parts advanced by Kant, 
see Keith N. Hylton, The Law and Ethics of Organ Sales, Annual Review of Law and Ethics, 115-136, at 
118-199, Band 4 (1996).  Kant’s original argument against selling body parts includes exceptions and 
qualifications that can be interpreted as approving the sale of body parts for a sufficiently important 
purpose, such as saving a life.  Id. 
14 Beauchamp and Childress, at 32. 
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Virtues, since Plato, have been upheld as a set of motives that are wholly different 
from and in opposition to self interest.  It was also fundamental to Plato’s conception of 
an ideal society that the relentless pursuit of financial gain should be undertaken by a 
class that would be excluded from consideration as moral guardians.  The reason is 
straightforward: the pursuit of financial gain may put pressure on the actor to 
compromise his ethical integrity.  It is reassuring and a bit of a relief to see that this 
fundamental formulation of ethics remains largely unchanged, and requires no substantial 
reformulation for the context of health care. 
 
The question this raises is whether self interest deserves the treatment that it gets 
in Biomedical Ethics.  There are ethical arguments to be made in favor of self interest, or 
the seeking of advantage generally.  The tone of Beauchamp and Childress suggests that 
such arguments would strike biomedical ethicists as entirely foreign, at least in the 
context of health care. 
 
Adam Smith offered a direct refutation of the view that self interest should be 
viewed as a base impulse to be relegated to a confined sphere of society or perhaps 
eliminated.15  Of course, Plato did not argue that self interest should be eliminated from 
society altogether; he argued that it should be contained within a sphere inhabited by a 
second class of citizen.  At least Plato seemed to have a sense that there needed to be 
some engine to drive the economy and to serve as a means of practical administration, in 
the sense of allocating resources, within his ideal society.  Biomedical Ethics apparently 
envisions either no role at all, or a minuscule role at best, for self interest in the health 
care market. 
 
Self interest plays an important role in the organization of society.  It is through 
self interest that we obtain the degree of social organization that permits basic needs and 
desires to be met.  A system of social organization, such as the market, that takes 
advantage of self interest to ensure the supply of goods and services provides a solid 
foundation for its own existence and survival.  Self interest is not a mere byproduct of 
social organization.  It is a primitive fact which should be taken into account in any effort 
to design a system of social organization.  And given its existence as a basic human 
motivation hard-wired by evolution, an ethical system that failed to accord self interest 
any weight whatsoever in the design of appropriate social institutions would predictably 
fail. 
 
Self interest is a difficult concept to define.  Short-term self interest may and often 
does differ from long-term self interest.  A society probably could not function if every 
one of its members acted on the basis of myopically short-term self interest.  Indeed, 
myopic self interest has been identified as the core failure of some dysfunctional 
societies.16  Some level of trust and concern for others must exist, or at least be expressed 
in the actions of citizens for society to function reasonably well.17  And trust requires as a 
                                                 
15 Adam Smith, An Inquiry into the Nature and Causes of the Wealth of Nations (1776). 
16 Edward Banfield, The Moral Basis of a Backward Society (1958); see also Kenneth Arrow, Gifts and 
Exchanges, 1 Philosophy and Public Affairs 343, at 357 (1972). 
17 Arrow, supra note 15, 357-58. 
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prerequisite many of the classic virtues that ethicists describe.  A well functioning market 
system encourages the development of these virtues.  Indeed, the natural human tendency 
to trade long preceded the development of virtues as we know them now,18 and the 
virtues probably evolved as a byproduct of economic exchange.19 
 
There have been efforts to devise systems of social organization in which virtue 
rather than self interest would determine the extent to which needs are met.  What is most 
notable about these systems is that they generally have failed as resource allocation 
mechanisms, after developing societies that were remarkably thin in the conventional 
virtues.  The former socialist economies have experienced corruption and human 
trafficking on a scale that is far greater than that observed in market-based economies.20  
While the relatively large scale of corruption and human trafficking in transition 
economies may be attributed simply to poverty and the pressures of transition, some part 
of it may be due to a failure of these societies to develop or maintain the ethical norms 
that form a significant part of the social capital of market-based economies. 
 
III. Applications of Basic Terms: Commerce in Organs and the Duty of Beneficence 
 
It is with these general comments in mind that we should examine Beauchamp 
and Childress’s application of the concept of moral excellence to the organ donation 
setting.  Self interest, Beauchamp and Childress suggest, is an improper basis for 
providing an organ to an individual who needs a transplanted organ in order to survive.  
A physician, acting as moral gatekeeper, should refuse to accept a donation when it 
appears to be tainted by self interest. 
 
This view of the role of self interest in the supply of transplant organs is 
inconsistent with reality and questionable on ethical grounds.  It is inconsistent with 
reality because it fails to come to grips with the role self interest already plays in organ 
transplantation.  The physicians that harvest and transplant the organs are compensated, 
and many of them would not work in the field if they were refused compensation.  They 
are not asked to supply their time and skill on the basis of altruism.  The intermediaries 
that ship and prepare harvested organs for transplantation are sometimes profit-seeking 
firms.21  They are not asked to supply their services on the basis of altruism.  If they were 
                                                 
18 Paul Seabright, The Company of Strangers: A Natural History of Economic Life (Princeton Univ. Press, 
2004). 
19 Id.; A.O. Hirschman, The Passion and the Interests: Political Arguments for Capitalism Before Its 
Triumph (Princeton Univ. Press, 1977). 
20 On corruption in transition economies, see, e.g., Pashev, Konstantin V., Understanding Tax Corruption in 
Transition Economies: Evidence from Bulgaria (2006), available at SSRN: 
http://ssrn.com/abstract=931045; Hellman, Joel S., Jones, Geraint and Kaufmann, Daniel, Seize the State, 
Seize the Day: State Capture, Corruption and Influence in Transition (September 2000), World Bank Policy 
Research Working Paper No. 2444, available at SSRN: http://ssrn.com/abstract=240555.  On prostitution, 
see, e.g., Mihaly Simai, Poverty and Inequality in Eastern Europe and the CIS Transition Economies , 
DESA Working Paper No. 17, ST/ESA/2006/DWP/17, February 2006, available at 
http://www.un.org/esa/desa/papers/2006/wp17_2006.pdf. 
21 See, e.g., Katz, Robert A., "The Re-Gift of Life: Can Charity Law Prevent For-Profit Firms from 
Exploiting Donated Tissue and Nonprofit Tissue Banks?" . DePaul Law Review, Vol. 55, No. 3, pp. 943-
1015, 2006, available at SSRN: http://ssrn.com/abstract=892065. 
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refused any compensation whatsoever for their efforts in the transplantation process, they 
would not offer their services.  And, of course, much of the capital (equipment and 
structures) used in the transplantation process is produced by profit-making firms. 
 
If the physician, acting as moral gatekeeper, is authorized under the theory of 
biomedical ethics to refuse to allow a potential donor to donate his organ because the 
offer seems tainted by self interest, then shouldn’t the same withering gaze be applied to 
all of the other actors involved in the organ procurement process?  For the organ to be 
transplanted the initial raw material, the organ, must be present, and also the labor of the 
physicians involved must be present, as well as equipment specific to the transplantation 
process.  It is unclear to me why self interest is allowed to control the supply of almost all 
of the factors of production in organ transplantation, except for the organ donor.  For the 
physician to exercise his authority as moral gatekeeper, he must deny the authority of the 
individual donor to act upon the very same impulses that drive the physician’s conduct.  
To do so is incompatible with the principle of autonomy, because it fails to treat the 
individual donor as an equal, in moral terms, to the physician gatekeeper. 
 
Moreover, if we allow the ordinary individual to serve as a judge of virtue in the 
organ donation case, he will have to be allowed to consider the external evidence.  If the 
principle of autonomy means that all fair-minded people are capable of being judges of 
the morality of conduct, then self interest would have to be understood as a factor that 
infects the decision making of all involved.  The mere fact that it might be a motivation 
behind someone’s actions cannot by itself be a disqualifying factor.  The external judge, 
being unable to decide the matter on the simple ground that self interest has infected one 
party’s actions, will then have to consider the observable welfare effects of the donor’s 
decision. 
 
An examination of the welfare effects of a decision to donate, even though that 
decision may be tainted by self interest, is a potentially complicated analysis.  It is clear 
that the donation of an organ provides a substantial benefit to the potential recipient.  But 
the donation may be questionable on moral grounds if the donor is unaware of the costs 
he may suffer.22  And indeed, one may take the position that lack of information is so 
severe in this context that donors should not be allowed to enter into contracts for selling 
organs to be harvested while they are still alive.  But a contract to supply an organ after 
death involves far fewer potential costs to the donor.23  A rational ethical policy might, in 
the end, bar all sales inter vivos and permit only contracts to supply organs after death. 
 
                                                 
22 For a discussion of the ethics of organ donation that considers empirical evidence bearing on consent and 
other issues, see Mary Simmerling, Choosing to be Harmed: Autonomy and its Limits in Living Organ 
Donor Transplantation (September 20, 2005), available at SSRN: http://ssrn.com/abstract=896263. 
23 Lloyd R. Cohen, Increasing the Supply of Transplant Organs: The Virtues of a Futures Market, 58 Geo. 
Wash. L. Rev. 1 (1989); Lloyd R. Cohen, Increasing Supply, Improving Allocation, and Furthering Justice 
and Decency In Organ Acquisition and Allocation: The Many Virtues Of Markets, 1:3 Graft 122 
(July/August 1998); Richard Schwindt and Aidan R. Vining, Proposal for a Future Delivery Market for 
Transplant Organs, 11 Journal of Health Politics, Policy and Law 483 (1986); Henry Hansmann, The 
Economics and Ethics of Markets for Human Organs, 14 J. Health, Politics, Policy, and Law 57 (1989). 
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Whatever a rational ethical policy would entail, it probably would not bar every 
transaction in which the organ donor appears to be motivated by the receipt of a financial 
reward.  Such a policy would be unethical within the framework of Biomedical Ethics in 
the sense that it fails to respect the autonomy of the individual and treats him as less than 
the moral equal of the gatekeeping physician.24  It would be unethical in practical 
utilitarian terms because it denies a clear and substantial gain to the desiring recipient in 
some cases in which the loss to the donor is trivial (e.g., the transfer occurs after death of 
the donor).25 
 
In a system of ethics that takes the principle of autonomy seriously, the proper 
role of the gatekeeping physician is to ensure that the potential organ donor is in a 
position to serve as a fully informed judge of the morality of his own conduct; and, if that 
is not possible, to constrain his decisions only on the ground that the potential donor 
appears to be unable to serve in this fashion.  In other words, informing the potential 
donor of the potential costs he may bear or he may impose on others is the first ethical 
requirement of the gatekeeping physician.  That implies a dialogue between the potential 
donor and the physician in which the two work their way toward a common 
understanding of the right decision.  Such a dialogue starts from the premise that the 
donor and physician are equals on moral grounds. 
 
One could assert that no system of ethics should require the physician to perform 
a medical procedure that he or she finds ethically abhorrent.  Surely, one might argue, in 
a system that treats all actors as potentially equal in moral status, this has to be conceded.  
However, the gatekeeping physician’s position should foist on him a duty to bend away 
from rigid adherence to abstract principles in order to improve the welfare of the patients 
he is charged to care for.  Integrity is cited by Beauchamp and Childress as one of the 
important virtues,26 but it has a price.  If the price of integrity in this setting is that a 
potential organ recipient must forgo a new organ, or return to the waiting list, then the 
gatekeeping physician’s concern for ethical integrity becomes a source of substantial 
harm. 
 
The role of implicit prices, or cost-benefit analysis in general, suggests a larger 
problem in Biomedical Ethics.  Most ethicists have a strong attachment to principles as 
well as an aversion to the constant balancing of interests done by economists and 
utilitarians.  The same tendency to set out principles to guide conduct is observed in 
                                                 
24 It should be obvious that I am setting aside the case of an incompetent party, when the gatekeeping 
physician must act paternalistically.  Instances in which one party is incapable of making a decision 
(because he is unconscious, brain dead, etc.) occur frequently in the medical care context.  It is clear that a 
physician cannot be asked to treat the incompetent party as an “equal” in the decision making process.  
However, even in this set of cases, the law has developed rules respecting the autonomy of substitute 
decision makers.  These rules effectively limit the discretion of the gatekeeping physician.     
25 Even if the transfer occurs while the donor is alive, one should be able to argue persuasively, on ethical 
grounds, that an individual, or consenting parties, should have a right to take reasonable risks in order to 
preserve a life.  For an effort to tie this argument into the law, see Volokh, Eugene, Medical Self-Defense, 
Prohibited Experimental Therapies, and Payment for Organs,  Harvard Law Review, Vol. 120, April 2007, 
available at SSRN: http://ssrn.com/abstract=941868. 
26 Beauchamp and Childress at 35-37. 
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Beauchamp and Childress.  Of course, recognizing the difficulty of solving real problems 
with broad moral principles, Beauchamp and Childress provide several multi-step 
algorithms for solving particularly knotty problems.  But these multi-step algorithms 
invariably appear to be equivalent to cost-benefit analysis, just dressed in different 
garments. 
 
For example, consider the following set of principles Beauchamp and Childress 
set out for dealing with “specific beneficence and the obligation to rescue”.27  Beauchamp 
and Childress say that  
 
Apart from special moral relationships, such as contract or the ties of 
family and friendship, a person X has a determinate obligation of 
beneficence toward person Y if and only if each of the following 
conditions is satisfied (assuming X is aware of the relevant facts): 
 
1.Y is at risk of significant loss of or damage to life or health or some 
other major interest. 
2.X’s action is needed (singly or in concert with others) to prevent this 
loss or damage. 
3.X’s action (singly or in concert with others) has a high probability of 
preventing it. 
4.X’s action would not present significant risks, costs, or burdens to X. 
5.The benefit that Y can be expected to gain outweighs any harms, costs, 
or burdens that X is likely to incur.28 
 
Thus, according to Beauchamp and Childress, conditions 1 through 5 present necessary 
and sufficient conditions for the existence of a moral duty to rescue.  Since the foregoing 
proposition refers to an obligation of beneficence, Beauchamp and Childress presumably 
have more in mind than rescue situations.  Perhaps the beneficence proposition applies to 
any setting in which X is capable of doing something to help Y. 
 
The foregoing beneficence proposition is an example of an effort to take an 
abstract utilitarian principle and crystallize it in the form of an ethical rule of conduct.  In 
tort law, the basic utilitarian principle has been described as the Learned Hand formula,29 
which compares the burden of precaution (B) with the expected harm that could be 
avoided by taking a particular precaution.  If P is the probability that harm will come to 
the victim, and L the victim’s loss, the expected harm that could be avoided by taking 
precaution is PL.  Under the Learned Hand formula, an actor should take a precaution to 
avoid causing an injury to another if and only if: 
 
B < PL. 
 
                                                 
27 Id. at 170. 
28 Id. at 171. 
29 The Learned Hand Formula was stated by Judge Learned Hand in United States v. Carroll Towing, 159 
F.2d 169 (2d Cir. 1947). 
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The Learned Hand formula can be applied easily to the rescue scenario.  In the rescue 
scenario, one should compare the burden of a rescue with the expected harm that could be 
avoided by the rescue.  If the burden is less than the expected harm that could be avoided, 
then the utility maximization objective requires rescue. 
 
The utilitarian approach immediately suggests the rules stated in the beneficence 
proposition of Beauchamp and Childress.  But it also suggests a large number of 
variations on those rules.  For example, suppose X’s action has a low to moderate 
probability of preventing the loss to Y.  Rescue may still be required under the utilitarian 
norm if Y’s potential loss is extremely large (for example, an outcome that some might 
consider worse than death) and the burden of rescue is slight.  Similarly, the utilitarian 
norm might require X to incur a significant risk if the benefit to Y is sufficiently large. 
 
What this suggests is that the beneficence proposition stated by Beauchamp and 
Childress is not a principle as much as an attempt to summarize the implications of cost-
benefit analysis.  Because its justification is grounded in cost-benefit analysis, it is 
somewhat misleading to suggest to the student that these are principles in the sense of 
categorical imperatives.  Moreover, the beneficence proposition is incomplete to the 
extent that it fails to set forth all of the implications of the utilitarian norm that underlies 
it. 
 
Beauchamp and Childress apply the beneficence principle to McFall v. Shimp.30  
Robert McFall had contracted aplastic anemia.  His physician believed that a bone 
marrow transplant could greatly improve his chance of survival.  McFall’s cousin, David 
Shimp, agreed to be tested for tissue compatibility, and the test showed that Shimp was a 
compatible donor.  However, Shimp refused to submit to a second test, for genetic 
compatibility.  McFall sued to force his cousin to submit to the second test and to donate 
bone marrow if the second test showed genetic compatibility.  The court agreed that 
Shimp’s conduct was morally indefensible, but ruled in favor of Shimp. 
 
Beauchamp and Childress argue that the court’s holding in McFall v. Shimp is 
consistent with the beneficence proposition.  They say that although the first two 
conditions were satisfied in that case, the third condition (X’s action has a high 
probability of preventing the harm to Y) was not clearly satisfied.  The reason they offer 
in support of this view is that “McFall’s chance of surviving one year would have only 
increased from 25 to between 40 and 60 %”.31  They also suggest that condition four was 
not clearly satisfied because even though the risk incurred by the bone marrow donor is 
minimal, Shimp “believed the risks were greater.”32 
 
This is a highly questionable argument, and most likely wrong in key respects.  
The court’s sense that Shimp’s conduct should be criticized on moral grounds was 
probably correct.33  First, the third condition of the beneficence principle appears to have 
                                                 
30 10 Pa.D. & C. 3d 90 (1978). 
31 Beauchamp and Childress, at 171. 
32 Id. at 172. 
33 Id. at 172 (quoting court’s description of Shimp’s conduct as “morally indefensible”). 
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been satisfied in this case.  A medical procedure that increases a gravely ill person’s one-
year survival rate from 25 to as much as 60 percent should be considered an action that 
has a high probability of preventing the harm the person seeks to avoid, in this case death.  
I doubt that the typical physician would view such a procedure as a long shot approach 
toward enhancing survival odds.  Second, the fourth condition of the beneficence 
principle appears to have been satisfied too.  The risk associated with bone marrow 
donation is minimal, and the physicians had disclosed the risk to Shimp. That he chose to 
cling to an unfounded belief that the procedure would impose a great risk of harm on him 
is not an argument for finding against the existence of a moral obligation to rescue.  The 
important question in the application of the beneficence principle is whether a reasonable 
person would regard the risks incurred in rescue as substantial.  Shimp’s belief that the 
risk was substantial is different from that of a reasonable person, and for that reason 
should not factor in an application of the beneficence principle. 
 
If it is clear that the court’s holding in McFall v. Shimp is inconsistent with the 
beneficence principle, then is it possible to justify the decision on any theoretical basis?  
The decision in McFall v. Shimp is not at all surprising to anyone familiar with the law on 
consent to bodily invasions.  There are other decisions in which courts have sided with 
defendants who refused to submit to some invasive procedure when the moral case for 
forcing submission was obviously strong.34  The core justification for decisions such as 
McFall v. Shimp is that the law requires the consent of the patient before any invasive 
medical procedure is deemed lawful, unless the conditions are such that consent would be 
almost impossible (e.g., medical emergency). 
 
IV. Consent, Autonomy, and Self Interest in Biomedical Ethics 
 
The student of ethics should be willing to dig further and ask why the law requires 
the consent of the patient to any invasive medical procedure.  The most likely reason is 
that a rule permitting invasive medical procedures to be conducted in the absence of 
consent opens the door to a potentially troubling universe.  The law does not permit 
others to decide when our bodies should be used in order to enhance social welfare.  
Naturally, this basic norm leads to troubling cases such as McFall v. Shimp.  But an 
alternative rule, one permitting invasive procedures in the absence of consent, would 
generate more worrisome incentives.  
 
The fundamental legal norm requiring consent is itself justifiable on the basis of a 
simple and familiar conceptual framework.  If the cost of bargaining to reach an 
agreement to transfer an entitlement is relatively low, we should strongly encourage a 
consensual transaction.  Property rules, as defined by Calabresi and Melamed,35 are legal 
rules that protect holders of entitlements by forcing those who would wish to acquire 
                                                 
34 See e.g., Doe v. Doe, 632 N.E.2d 326 (Ill. App. 1994) (competent pregnant woman has absolute right to 
refuse caesarean section even if the refusal may harm the fetus). 
35 Guido Calabresi & A. Douglas Melamed, Property Rules, Liability Rules, and Inalienability: One View 
of the Cathedral, 85 Harv. L. Rev. 1089 (1972).  For a modern application of Calabresi-Melamed, see Keith 
N. Hylton (2006), Property Rules and Liability Rules, Once Again, Review of Law & Economics: Vol. 2: 
No. 2, Article 1, available at: http://www.bepress.com/rle/vol2/iss2/art1. 
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them to bargain to gain access or possession.  In the law, we observe property rules 
protecting such basic entitlements as exclusive possession of property and freedom from 
undesirable physical contact.  The law in these areas permits the potential victim to 
enjoin a threatened violation and to seek compensatory damages if a violation occurs. 
 
If the cost of bargaining to reach an agreement to transfer an entitlement – i.e., the 
transaction cost – is relatively high, we may prefer to permit nonconsensual transfers to 
occur with only a right to seek compensation ex post given to the victim.  In this set of 
cases, a liability rule applies.  For example, the cost of bargaining to reach an agreement 
permitting the imposition of risk in the traffic setting would be extremely high.  No one 
has time to bargain with everyone that they might possibly run into with their car.  In 
these settings, the law makes no attempt to encourage or force ex ante agreements. 
 
There is a third category identified by Calabresi and Melamed that is governed by 
the inalienability rule.  The inalienability rule protects holders of entitlements by forcing 
those who wish to acquire them to bargain for access.  However, the inalienability rule 
also prohibits or severely constrains the holder’s right to enter into a transaction to sell 
the entitlement.  The entitlement holder is permitted, instead, to make a gift of the 
entitlement.36  Given that the inalienability rule requires bargaining for access, it applies 
in low transaction cost settings, like the property rule, and provides property-rule like 
protection from expropriation to the holders of entitlements.  The inalienability rule 
efficiently prohibits sale transactions when the seller is unlikely to accurately perceive his 
own objective or subjective valuation of the entitlement, and when the subjective loss 
associated with a transfer is likely to be severe. 
 
McFall v. Shimp is a straightforward example of the application of a property rule 
in the sense of Calabresi and Melamed.  On utilitarian grounds, the proper moral outcome 
would have required Shimp to submit to a test for genetic compatibility and, most likely, 
to serve as a marrow donor to McFall.  But the law does not attempt to align itself 
consistently with utilitarianism, at least in the sense of balancing interests in the short run.  
The law has tended, instead, to develop areas of entitlement and autonomy in settings in 
which the costs of transaction are low.  This approach encourages consensual 
transactions. 
 
Why should there be a preference on ethical grounds for consensual transactions?  
To someone who is unfamiliar with the arguments of ethicists, this might appear to be a 
bizarre question.  Is it not obvious, they might respond, that we should prefer voluntary 
over coerced transactions?  But the biomedical ethics literature does not appear to reflect 
this commonsense viewpoint.  One searches in vain in Beauchamp and Childress for the 
suggestion that consensual transactions might deserve some special deference on ethical 
grounds.  This is entirely consistent with a viewpoint that never fully embraces the 
                                                 
36 Inalienability rules can come in a variety of forms.  The rule considered here permits gifts and prohibits 
sales.  However, some rules may prohibit sales and gifts.  For an economic analysis, see Susan Rose-
Ackerman, Inalienability and the Theory of Property Rights, 85 Columbia L. Rev. 931 (1985).  A moral 
account of inalienability rules, see Margaret Jane Radin, Market Inalienability 100 Harv. L. Rev. 1849 
(1987).  
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concept of autonomy.  Giving deference to consensual transactions, on ethical grounds, 
immediately suggests a willingness to allow individuals to serves as their own ethical 
gatekeepers.  However, this would diminish the role of the medical ethicist. 
 
Limited information and self-interest, two primitive features of the human 
condition, provide a sufficient basis for preferring consensual transactions on ethical 
grounds.  Consider the limited information problem first.  An ethical social planner, such 
as Beauchamp and Childress’s gatekeeping physician, may sincerely have the best 
interests of all parties in mind when he decides whether a certain transaction should or 
should not be permitted on ethical grounds.  But unless the gatekeeping physician is 
perfect, he will occasionally err by requiring a transaction to take place when it reduces 
the welfare of both parties or blocking a transaction that would have increased the sum of 
the welfare of both parties. 
 
This argument implicitly assumes that welfare is an important concern to the 
ethicist.  If Beauchamp and Childress are taken as exemplary of the field of medical 
ethics, it is clear that social welfare is an important concern to the medical ethicist.  The 
beneficence principle and other practical problem-solving algorithms set out in their book 
are clearly utilitarian in structure.  However, even if Beauchamp and Childress had not 
revealed an overarching concern for social welfare in the framing of their problem-
solving tests, I would hold that social welfare should be a fundamental concern to the 
ethicist. And assuming that a system of ethics would attempt to produce results that are 
consistent with maximizing some conception of social welfare, consensual transactions 
should be granted some deference on the ground that the ethicist’s limited information 
hampers his ability to make accurate assessments of welfare-enhancing transactions. 
 
To take an example of the limited information problem, suppose A proposes to 
donate an organ to B for a minimum asking price of PAsk.37  Suppose that B is willing to 
pay a maximum offer price of POffer, where POffer  > PAsk.  In order to donate the organ, A 
has to incur medical and travel expenses equal to Po.  In addition to such out-of-pocket 
expenses, the loss of an organ (through donation) may reduce A’s long-term ability to 
work, leading to some reduction in lifetime earnings equal to Pw.38  Finally, A expects to 
incur additional subjective costs Ps – e.g., perhaps the organ fails in the recipient, and A 
                                                 
37 This argument is based on Keith N. Hylton, The Law and Ethics of Organ Sales, Annual Review of Law 
and Ethics, 115-136, Band 4 (1996) and Keith N. Hylton, The Law and Economics of Organ Procurement, 
12 Law & Policy 197 (1990).  For a discussion of the economics of organ sales with an up-to-date 
empirical evaluation of the market for organs, see Gary Stanley Becker and Julio Jorge Elias, Introducing 
Incentives in the Market for Live and Cadaveric Organ Donations, forthcoming Journal of Economic 
Perspectives, available at 
http://home.uchicago.edu/~gbecker/MarketforLiveandCadavericOrganDonations_Becker_Elias.pdf.  Probably the 
first article providing an economic analysis of the organ shortage and advocating a market for organs is 
Marvin Brams, Transplantable Human Organs: Should Their Sale Be Authorized by State Statutes?” 3 Am. 
J. L. and Medicine 183 (1977).  Several scholars have noted that a market for transplantable organs 
effectively exists today, although it is an unregulated black market.  See, e.g., Michele Goodman, Black 
Markets: The Supply and Demand for Body Parts (Cambridge Univ. Press, 2006).  
38 More generally, Pw can be taken to represent the monetized value of the reduction in lifetime utility that 
results from giving up an organ.  The reduction in lifetime utility may include effects from a reduction in 
work-life and also effects from a reduction in the capacity to enjoy recreational activities as well. 
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experiences disappointment from knowing that his effort provided little help to anyone in 
the end.39  Under these assumptions, A’s minimum asking price is 
 
PAsk = Po + Pw + Ps . 
 
A medical ethicist, or gatekeeping physician, presumably would object to the proposal on 
ethical grounds if he observes that the price demanded by the donor exceeds his out-of-
pocket expenses (Po < PAsk).  The ethicist presumably would say that there is nothing 
ethically objectionable about A having his costs covered, receiving a price sufficient to 
compensate A for his out-of-pocket expenses.  But the ethicist would object to this 
particular transfer if it appears to provide a “profit” of PAsk – Po to the donating party A.  
This conclusion could easily be wrong on ethical grounds, because of the ethicist’s 
limited information.  A’s decision to donate imposes unobserved costs on him equal to 
the sum of reduced lifetime earnings and subjective costs (Pw + Ps).  Allowing the 
transaction to take place at a price of PAsk would result in no gain in welfare to A and a 
gain in welfare to B of POffer – PAsk.  In other words, even if we accept the proposition that 
earning a profit would corrupt A’s offer on ethical grounds, such a complaint would be 
inapplicable in this example. 
 
Generalizing slightly on this example, what are the characteristics of the type of 
organ donation transaction that the gatekeeping physican will approve?  He will approve 
a transaction when it appears that the donor’s demand price (PAsk) is just sufficient to 
cover the donor’s out-of-pocket expenses (Po).  Since the donor’s demand price is equal 
to the sum of out-of-pocket, lifetime earnings, and subjective costs, this is equivalent to 
saying that the gatekeeping physician will approve transactions only when the sum of the 
lifetime-earnings and subjective components is equal to zero (Pw + Ps = 0).  When will 
this occur?  The most likely scenario is when the subjective component is substantial and 
negative, which means that the donor experiences a large subjective benefit from 
donation.  This will be observed largely when the donor is giving the organ to a family 
member.  But why should the transaction with a family member be privileged relative to 
one in which the donor demands a larger price because the subjective cost component is 
positive rather than negative? 
 
As this example illustrates, the gatekeeping physician’s limited information leads 
to a result in which he enforces rules that fail to bear a strong relationship with the 
underlying ethical norm.  The underlying ethical norm is to deny organ donation 
transactions that produce a gain, advantage, or profit to the donor.  This leads the 
gatekeeping physician to deny transactions in which the demand price significantly 
exceeds the donor’s out-of-pocket expenses and to otherwise approve the transaction.  
But the transactions between live donors and potential recipients that are approved, 
                                                 
39 The expected cost of disappointment is a subjective cost at the time of the transaction only to the extent it 
is foreseeable to the organ provider.  More generally, the subjective cost includes any perceived cost that 
cannot be described as an objective expense (such as medical costs or wage loss).  For example, the 
perceived cost of violating religious norms may fall under this category.  The low rate of donation by 
minorities may reflect the perceived cost of violating religious norms or a fear that they may be exploited. 
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largely donations to family members, are also instances in which the donor experiences a 
real gain and therefore appear to violate the underlying ethical norm.   
 
Consider the following numerical example.  Assume two potential organ donors, 
Sam and Al, would each experience out-of-pocket expenses (Po) of $200 and expected 
future-earnings losses (Pw) of $500 in connection with the donation of an organ.  
However, Sam’s subjective cost is, translated into monetary terms, $0, while Al’s 
subjective cost is -$1000.  Al’s subjective cost is negative and large (in absolute value) 
because he is donating to a relative.  If Sam demands a price of $700, his proposed 
transaction will be rejected because he would appear to the gatekeeping physician to be 
gaining a profit of $500 ($700 price less $200 out-of-pocket expenses).  However, Sam’s 
real profit is $0 in his proposed transaction.  Suppose Al, on the other hand, demands a 
price of $200.  His proposed transaction would be accepted by the gatekeeping physician 
because he would not appear to be gaining a profit, since his demand price of $200 would 
be just sufficient to cover his out-of-pocket expenses.  Al’s real gain, however, would be 
equal to $500 (the demand price $200, less out of pocket expenses of $200, less expected 
future losses of $500, less the subjective cost of -$1000).  In this example, the more 
altruistic of the two donors is Sam.  However, Sam’s proposed transaction is the one most 
likely to be rejected as unethical. 
 
It may be desirable still to block organ donation transactions in which the donor’s 
demand price exceeds the donor’s out-of-pocket expenses on the ground that the donor 
lacks sufficient information or the ability to evaluate the long-term consequences of his 
decision.40  If the donor gives the organ for free or for a small price to a family member, 
he may perceive the donation as an act of sharing in the organ recipient’s misfortune.  If 
the donor suffers unexpected harmful consequences as a result of the donation, it may 
simply reaffirm his perception of sharing in misfortune.  If the recipient is someone for 
whom he cares deeply, he may perceive sharing in the misfortune as a proof of the depth 
of his concern for the recipient’s welfare.  On the other hand, if the donor sells the organ 
for financial gain to a stranger, he may perceive severe regret if the long-term 
consequences are more harmful than he had anticipated.  Because the likelihood of regret 
is so much higher in the case of a transaction with a stranger, it may be justifiable to have 
a rule that prohibits transactions that appear to generate a financial gain, largely on the 
ground that this rule effectively prohibits live donations to strangers. 
 
The potentially severe subjective loss associated with regret would be a defensible 
ethical reason for adopting a policy of blocking organ donation transactions in which the 
price exceeds out-of-pocket expenses.  However, it is fundamentally independent of the 
donor’s likelihood of gaining financially.  Evidence suggesting that the donor gained 
financially would serve under this rationale only as sign suggesting that the risk of regret 
is worrisomely high.  There would be nothing ethically troubling in itself with the 
evidence that the donor had received a price in excess of out-of-pocket expenses. 
                                                 
40 An alternative reason to block the exchange is that the external harms imposed on bystanders who object 
to the sale are greater than the surplus to the contracting parties, see Calabresi and Melamed, at 1111-12.  




The other basis for preferring consensual transactions on ethical grounds is self 
interest.  Self interest is a primitive fact.  A sound ethical theory must assume that it 
exists and is a motivation for the decisions of all actors.  Recognizing the existence of 
self interest, why should society prefer a method of social organization that grants a third 
party, himself motivated by self interest, the right to block consensual transactions on 
ethical grounds? 
 
Because of self-interest, the gatekeeping physician may decide to block welfare-
enhancing transactions because he perceives some payoff from doing so.  Suppose the 
gatekeeping physician enjoys a payoff from developing a reputation for enforcing ethical 
norms.  He may decide that the payoff to himself is more valuable than the empathetic 
disutility he feels for the parties whose transaction he has just denied.  Returning to the 
concrete example just offered, suppose the gatekeeping physican perceives a payoff of Pr 
from being seen to enforce rules that he equates with ethical norms.  One such rule is to 
deny a proposed organ donation when the donor also proposes a price that appears to 
exceed the observed cost to the donor.  In the example above, welfare is enhanced by the 
denial only if Pr > POffer – PAsk.  Since the gatekeeping physician is not a party to the 
transaction, however, he will clearly deny the transaction whenever his perceived payoff 
is positive (Pr > 0).  That will result in many denials that reduce social welfare. 
 
Information disclosure is another issue that has long captured the attention of 
biomedical ethicists.  Biomedical Ethics treats the law in this area as another illustration 
of ethical rules in operation.  However, the information disclosure requirement that has 
developed in the common law is a byproduct of the recognition of bodily integrity as an 
entitlement protected by a property rule.  Indeed, bodily integrity is also protected by a 
rule of inalienability: not only is it unlawful to invade someone’s body without consent, 
but the law does not even give the individual the right to sell claims to his body.  With 
this hard barrier of protection surrounding the entitlement to bodily integrity, it follows 
naturally that the law would develop rigorous disclosure requirements for invasive 
medical procedures.  The disclosure requirements observed in the context of health care 
are a byproduct of the rules protecting underlying entitlements.  Where mere property 
rules apply, disclosure requirements are governed by the common law of fraud and 
misrepresentation.  Where the inalienability rule applies, as in the health care setting, the 
law requires a more complete disclosure that includes possible financial interests in the 




As cases such as McFall v. Shimp illustrate, the common law governing health 
care has developed in a pattern consistent with the property and liability rules framework 
of Calabresi and Melamed.  In other words, where the costs of transacting are low, the 
common law has tended to recognize spheres of autonomy.  The breach of such a sphere 
has been treated harshly.  A physician who refuses to gain consent from the patient for an 
                                                 
41 See, e.g., Moore v. Regents of the University of California, 793 P.2d 479 (Cal. 1990) (under the informed 
consent law, physician must disclose financial interest in invasive medical procedure). 
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invasive procedure, where such consent could have been obtained with a reasonable 
effort, is guilty of battery, even though ethical norms might justify the physician’s 
conduct.42  In addition, the physician who fails to properly disclose the risks associated 
with a medical procedure can be held liable for breaching his duty to the patient.43 
 
The introduction of the biomedical ethicist does no harm if he reaches conclusions 
that are entirely consistent with the common law, and with its most reliable underlying 
rationales.  However, if the biomedical ethicist exists for the purpose of reaching 
conclusions that would be rejected by the common law, as Beauchamp and Childress 
suggest in their treatment of McFall v. Shimp, he is unlikely to improve social welfare.  
The common law has developed over time by examining precisely the sort of tradeoff 
questions considered by the biomedical ethicist, and it has developed decision rules that 
are for the most part defensible on welfare grounds.  Reexamining the same tradeoff 
questions, the biomedical ethicist is unlikely to do better. 
 
 
                                                 
42 E.g., Mohr v. Williams.014 N.W. 12 (Minn. 1905). 
43 Canterbury v. Spence, 464 F.2d 772 (D.C. Cir. 1972). 
